It has been shown that p‐tau T217 species (quantified as the pT217/T217 ratio) highly correlate with amyloid lesions in the brain, cognitive decline, and tau positron emission tomography (PET) imaging in AD [31]. This evidence concerns the gene MAPT and Alzheimer disease.